United States · FDA National Drug Code directory
Bupivacaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71351-022_484033d6-ca7d-f0fd-e063-6294a90a7890
- Product NDC
- 71351-022
- Form
- INJECTION
- Composition / generic term
- Bupivacaine hydrochloride
- Labeler
- Brookfield Pharmaceuticals, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221031
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 7.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 AMPULE in 1 PACKAGE (71351-022-10) / 2 mL in 1 AMPULE (71351-022-02) · 71351-022-10
- 50 AMPULE in 1 PACKAGE (71351-022-50) / 2 mL in 1 AMPULE (71351-022-02) · 71351-022-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →